Long-term efficacy and safety of first- and second-generation baroreflex activation devices in refractory hypertension: a single center retrospective analysis
Background Baroreflex activation therapy (BAT) has emerged as a device-based therapy for resistant hypertension. Comparative evidence between first-generation (Rheos®) and second-generation (Barostim Neo™) BAT systems remains limited.Methods We retrospectively analysed all patients who underwent BAT...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2026-12-01
|
| Seria: | Blood Pressure |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.tandfonline.com/doi/10.1080/08037051.2026.2629644 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|